Amanote Research
Register
Sign In
Modulation of Human Immunodeficiency Virus Type 1 Synergistic Inhibition by Reverse Transcriptase Mutations
doi 10.1021/bi052362v.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Substrate Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
RNA Pseudoknots That Inhibit Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Incorporation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Into Virus-Like Particles
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus-1 Reverse Transcriptase Heterodimer Stability
Protein Science
Biochemistry
Medicine
Molecular Biology
The Structure of Unliganded Reverse Transcriptase From the Human Immunodeficiency Virus Type 1.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Antiviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Occur in Specific RNA Structural Regions.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Reduced dNTP Interaction of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Promotes Strand Transfer
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
